ANN – Credit Suisse rates the stock as Upgrade to Outperform from Neutral

By Broker News | More Articles by Broker News

Raw material prices have eased. Raw materials account for around 60% of the company’s cost of goods sold. Credit Suisse expects Ansell will achieve only a modest benefit in the second half but forecasts a benefit of around 5% for the first half of FY20.

The broker suspects the company will miss its 3-5% organic growth target in FY19, given indications that demand has moderated.

While wary of a subdued macro economy, Credit Suisse still expects 13% growth in earnings per share in FY20 and upgrades to Outperform from Neutral. Target is raised to $27.50 from $24.00.

Sector: Health Care Equipment & Services.

Target price is $27.50.Current Price is $26.50. Difference: $1.00 – (brackets indicate current price is over target). If ANN meets the Credit Suisse target it will return approximately 4% (excluding dividends, fees and charges – negative figures indicate an expected loss).

 

Broker News

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →